Search

ProsTIC clinical trials currently open  PRIMARY2: Prospective multi‐centre Randomised trial of the additive diagnostic value of PSMA PET in men with negative/equivocal MRI in the diagnosis of... Read more

Our Sunshine campus is located at 176 Furlong Road, St Albans on Wurundjeri Woi-Wurrung Country - click on the image below for an interactive map:   We are a public health service provider, providing... Read more

Cancer patients in Australia and the United States will benefit from a new research-focused collaboration between the Peter MacCallum Cancer Centre and Dana-Farber Cancer Institute in Boston.Through a Memorandum of... Read more

ProsTIC Leadership Team Professor Michael Hofman - Director of Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC); Nuclear Medicine and Molecular Imaging Physician  Professor Declan Murphy - Director... Read more

The Australian Cancer Research Fund (ACRF) has awarded Peter Mac $3 million to create the ACRF Centre for Cellular Imaging of Precision Immunotherapy to better determine which cancer patients will respond to immunotherapy. This... Read more

Peter MacCallum Cancer Centre and Cartherics Pty Ltd have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR T-cell therapy (CTH-001) for the... Read more